News Snapshot:
The WHO's regulatory director expects there will be no reason for the global health body to change its assessment that the benefits of the AstraZeneca vaccine outweigh risks, though it is closely studying reports of blood clots. © Reuters Nikkei staff writers April 5, 2021 08:44 JST Updated on April 7, 2021 10:28 JST | East Asia Copy Copied Nikkei Asia is tracking the spread of the coronavirus that was first detected in the central Chinese city of Wuhan. Cumulative global cases have reached 132,273,299, according to Johns Hopkins University in Baltimore. The worldwide death toll has hit 2,870,797. For...
